Quantcast
Potential Cause Of Preeclampsia Identified

Potential Cause Of Preeclampsia Identified

Nationwide Children's Hospital New research has identified a potential cause of and a better diagnostic method for preeclampsia, one of the most deadly and poorly understood pregnancy-related conditions in the world. The international team,...

Latest Alzheimer's disease Stories

2014-07-21 12:25:38

Blockbuster Status Awaits Novel DMTs and Lundbeck/Otsuka's Emerging Symptomatic Agent Lu-AE58054, According to Findings from Decision Resources Group BURLINGTON, Mass., July 21, 2014 /PRNewswire/ -- Decision Resources Group finds that the market for Alzheimer's disease (AD) therapies will more than triple, reaching nearly $12 billion by 2023, owing largely to the forecasted launch of the first disease-modifying therapies (DMTs), a landmark event in AD treatment. In 2023, these novel...

2014-07-18 08:22:31

Tony-award winning actress Laura Benanti emcees event; Endometriosis Foundation of America, co-founded by Tamer Seckin, MD, and Top Chef host Padma Lakshmi present fellowship award MANHASSET, N.Y., July 18, 2014 /PRNewswire-USNewswire/ -- The multi-platinum, Grammy award-winning band Train took center stage Wednesday evening in Oyster Bay, NY for a private benefit concert supporting The Feinstein Institute for Medical Research. The event also featured Endometriosis Foundation of...

2014-07-17 16:26:33

MELBOURNE, Australia, July 17, 2014 /PRNewswire/ -- Prana Biotechnology (NASDAQ: PRAN; ASX: PBT) has today provided an update on its clinical development program for Alzheimer's disease. Professor Colin Masters, the Florey Institute of Neuroscience and Mental Health, The University of Melbourne, will today include data from Prana's Phase 2 IMAGINE and EURO trials in his presentation at the Alzheimer's Association International Conference in Copenhagen, Denmark. The presentation is...

2014-07-16 16:24:01

ABERDEEN, Scotland and SINGAPORE, July 16, 2014 /PRNewswire/ -- TauRx Therapeutics Ltd [http://www.taurx.com ] announced it has achieved its target enrollment of 833 subjects into one of its two ongoing multi-center Phase III clinical trials of LMTX(TM) [http://taurx.com/lmtx-for-ad ], a tau aggregation inhibitor, for the treatment of Alzheimer's Disease [AD]. This placebo-controlled clinical trial (Protocol TRx-237-015 [http://taurx.com/015-clinical-study.html ]) has...

2014-07-16 16:23:55

20,000 people have taken free online memory checkup since May launch TORONTO, July 16, 2014 /CNW/ - A free online brain health assessment for Canadians worried about their memory reached a milestone today. Cogniciti Inc. reports that 20,000 people have taken the memory checkup after seeing news stories announcing the launch of the free test. While not a diagnostic tool, the 20-minute assessment (available at www.cogniciti.com) is like a temperature check for the mind that will help a person...

2014-07-16 12:28:14

NEW YORK, July 16, 2014 /PRNewswire-USNewswire/ -- Alzheimer's disease affects approximately 5.2 million people in the United States alone, and it is the nation's sixth leading cause of death. A cure for this insidious killer has so far proven elusive, but that could soon change as a result of a breakthrough at the Technion-Israel Institute of Technology that sheds light on a key mechanism in the accumulation of protein plaques in the tissue of Alzheimer's disease patients. The...

2014-07-16 08:28:20

Study Results Presented at the Alzheimer's Association International Conference 2014 INDIANAPOLIS, July 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data showing that beta-amyloid imaging was associated with altered diagnosis and management of patients with Alzheimer's disease. Change in management was observed in both patients who met and did not meet the Appropriate Use Criteria (AUC), which were developed by the Society of Nuclear Medicine and Molecular...

2014-07-16 04:21:29

ATTN: Please refer to www.alz.org/aaic/press.asp or call (312) 335-4078 for individual stories included here that were presented before Wednesday, July 16, and have come off embargo. COPENHAGEN, Denmark, July 16, 2014 /PRNewswire-USNewswire/ -- New studies reported at the Alzheimer's Association International Conference 2014 (AAIC® 2014) in Copenhagen cover the spectrum of Alzheimer's disease and dementia research. Data includes advances in early detection and diagnosis, identifying...

2014-07-16 04:21:24

- New Brain Protein Connected for First Time to Cognitive Decline and Alzheimer's Disease. COPENHAGEN, Denmark, July 16, 2014 /PRNewswire-USNewswire/ -- Results from four research studies reported as "developing topics" at the Alzheimer's Association International Conference(®) 2014 (AAIC(®) 2014) in Copenhagen include significant advances in evidence regarding treatment and early detection of Alzheimer's disease and dementia, as well as new ideas in the basic brain science of dementia that...

2014-07-15 12:28:31

Two drugs to be studied in North America and Europe in volunteers at high risk for disease COPENHAGEN, Denmark, July 15, 2014 /PRNewswire/ -- Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs--an active immunotherapy and an oral medication--can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related